Natco launches Covid drug ahead of patent waiver nod

Hyderabad: Even as it has filed for a compulsory licence (CL) for Covid drug Baricitinib in India, Natco Pharma has already begun rolling out its generic version of the rheumatoid arthritis drug under the Barinat brand.

Natco launched its 4mg tablets at Rs 30 a piece on Thursday and stocks of the drug are already in the market, sources with know of the matter told TOI. The 4mg dosage tablet accounts for nearly 95% of the market for this drug for Covid treatment, they added. Barinat is priced at less than 1% or nearly one-hundredth the price of the innovator drug Olumiant, which is pegged at around Rs 3,230 per tablet.

According to analysts, by going ahead with a drug rollout without waiting for the CL, Natco runs the risk of being sued for infringement by the patent holder. While the patent for Olumiant is held by Incyte Holdings, the drug is marketed by giant Eli Lilly.

But Eli Lilly, which also got restricted emergency use approval for Baricitinib 2mg and 4mg from Central Drugs Standard Control Organisation (CDSCO) on Monday, said it is “working with local Indian pharma companies to execute royalty-free voluntary licensing agreements to accelerate manufacturing and distribution of the medicine in India during the pandemic”.

Related Posts

  • Pharma
  • March 27, 2024
  • 99 views
Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

Haryana has blacklisted Maiden Pharmaceuticals Ltd, based at Sonepat, for three years, thereby debarring the firm from participating in state tenders. All rate contracts issued to the firm have also…

  • Pharma
  • March 27, 2024
  • 67 views
DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

New Delhi: The Drugs Consultative Committee (DCC), the advisory committee formed by the Central government to advise the Central and state governments on matters that require uniform implementation of drug laws…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

Lee Health develops natural capsule for effective Heart care

Lee Health develops natural capsule for effective Heart care

Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down